We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IDYA market cap is 3.09B. The company's latest EPS is USD -1.5150 and P/E is -27.31.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.88M | 3.54M | 8.04M | 3.92M | 0 |
| Operating Income | -26.28M | -32.71M | -33.52M | -41.92M | -51.02M |
| Net Income | -23.64M | -27.93M | -27.44M | -33.96M | -39.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 19.54M | 27.94M | 50.93M | 23.39M |
| Operating Income | -44.27M | -35.34M | -50.27M | -62.5M | -134.43M |
| Net Income | -41.98M | -34.5M | -49.76M | -58.66M | -112.96M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 364.75M | 527.56M | 532.94M | 649.32M | 961.53M |
| Total Liabilities | 30.94M | 25.95M | 24.89M | 28.23M | 26.22M |
| Total Equity | 333.81M | 501.61M | 508.05M | 621.09M | 935.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 113M | 298.27M | 381.35M | 387.97M | 649.32M |
| Total Liabilities | 12.6M | 100M | 79.83M | 38.51M | 28.23M |
| Total Equity | 100.4M | 198.27M | 301.51M | 349.46M | 621.09M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -27.84M | -61.3M | -91.48M | -115.22M | -43.81M |
| Investing | 23.52M | -97.86M | -46.51M | -158.46M | -353.97M |
| Financing | 2.93M | 193.99M | 221.82M | 362.72M | 349.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -39.31M | 55.46M | -55.78M | -87.18M | -115.22M |
| Investing | 2.27M | -146.24M | -69.67M | -33.4M | -158.46M |
| Financing | 50.61M | 128.75M | 145.45M | 97.17M | 362.72M |
| Market Cap | 3.09B |
| Price to Earnings Ratio | -27.31 |
| Price to Sales Ratio | 131.95 |
| Price to Cash Ratio | 19.65 |
| Price to Book Ratio | 4.97 |
| Dividend Yield | - |
| Shares Outstanding | 74.56M |
| Average Volume (1 week) | 936.01k |
| Average Volume (1 Month) | 685.93k |
| 52 Week Change | 85.73% |
| 52 Week High | 47.735 |
| 52 Week Low | 20.90 |
| Spread (Intraday) | 5.02 (11.16%) |
| Company Name | IDEAYA Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ideayabio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
